Cited by 670Pluripotent Stem Cells ResearchCongenital heart defects researchMesenchymal stem cell research

Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming

Open access
Burridge, Paul W., Keller, Gordon, Gold, Joseph D., Wu, Joseph C.·2012·Cell Stem Cell

Abstract

Cardiovascular disease is a leading cause of death worldwide. The limited capability of heart tissue to regenerate has prompted methodological developments for creating de novo cardiomyocytes, both in vitro and in vivo. Beyond uses in cell replacement therapy, patient-specific cardiomyocytes may find applications in drug testing, drug discovery, and disease modeling. Recently, approaches for generating cardiomyocytes have expanded to encompass three major sources of starting cells: human pluripotent stem cells (hPSCs), adult heart-derived cardiac progenitor cells (CPCs), and reprogrammed fibroblasts. We discuss state-of-the-art methods for generating de novo cardiomyocytes from hPSCs and reprogrammed fibroblasts, highlighting potential applications and future challenges.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.stem.2011.12.013

Cites

132 of 132 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Lian X Hsiao C Wilson GF Zhu K Hazeltine L Azarin SM Raval KK Kamp TJ Palecek SP 2011 Small molecule modulation of canonical Wnt signaling is sufficient to induce robust cardiac differentiation in human pluripotent stem cells Cell Stem Cell In Press PMC3390875 22645348

Cited by

Sorted by citations

Authors
Burridge, P. W., Keller, G., Gold, J. D., & Wu, J. C.
Affiliations
  • Stanford Medicine (US)
  • University Health Network (CA)
  • Geron (United States) (US)
Corresponding author
Wu, Joseph C.
Venue
Cell Stem Cell
Publisher
Elsevier BV
Published
2012-01
Volume
10
Issue
1
Pages
16-28
ISSN
  • 1875-9777 (ISSN-L)
  • 1934-5909
OpenAlex
W2062298134
Cited by
670
References
132
Citations by year
2026: 20 · 2025: 26 · 2024: 28 · 2023: 38 · 2022: 32 · 2021: 54 · 2020: 38 · 2019: 46 · 2018: 45 · 2017: 57 · 2016: 68 · 2015: 65 · 2014: 69 · 2013: 49 · 2012: 33
FWCI
25.99
Type
journal article
Language
en
Open access
Locations
  • Cell stem cell (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (1dp2od004437-01)
  • National Institute on Aging (RC1AG036142)
  • National Heart, Lung, and Blood Institute (R33HL089027)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
Keywords
human pluripotent stem cells, direct reprogramming, fibroblast reprogramming, cardiac progenitor cells, cardiomyocyte differentiation, cardiac regeneration, cell replacement therapy, drug testing, disease modeling
MeSH terms
Adult, Cardiovascular Diseases, Cell Differentiation, Fibroblasts, Humans, Myocytes, Cardiac, Pluripotent Stem Cells, Cell Dedifferentiation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review